Oana M Dumitrascu Selected Research

Oana M Dumitrascu Research Topics

Disease

7	Stroke (Strokes) 03/2022 - 01/2017
5	Cognitive Dysfunction 10/2021 - 01/2018
4	Ischemia 03/2022 - 09/2013
3	Intracranial Arteriosclerosis (Cerebral Atherosclerosis) 07/2021 - 02/2019
3	Cerebral Amyloid Angiopathy (Congophilic Angiopathy) 01/2020 - 08/2018
2	Infarction (Infarctions) 03/2022 - 01/2022
2	Ischemic Stroke 08/2020 - 01/2016
2	Infections 08/2020 - 01/2019
2	Hemorrhage 01/2020 - 07/2017
2	Brain Ischemia (Cerebral Ischemia) 01/2020 - 01/2016
2	Amyloidosis 01/2020 - 01/2020
2	Vasculitis (Vasculitides) 01/2019 - 08/2018
2	Inflammation (Inflammations) 01/2019 - 08/2018
1	Edema (Dropsy) 03/2022
1	Amaurosis Fugax 03/2022
1	Transient Ischemic Attack 03/2022
1	Hypertension (High Blood Pressure) 03/2022
1	Dyslipidemias (Dyslipidemia) 03/2022
1	Migraine Disorders (Migraine) 01/2022
1	Scotoma (Scintillating Scotoma) 01/2022
1	Memory Disorders (Memory Loss) 10/2021
1	Munchausen Syndrome (Munchhausen Syndrome) 02/2021
1	Encephalitis (Encephalitis, Rasmussen) 11/2020
1	Pathologic Constriction (Stenosis) 11/2020
1	COVID-19 08/2020
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 08/2020
1	Fever (Fevers) 08/2020
1	Venous Thrombosis (Deep-Vein Thrombosis) 08/2020
1	Venous Thromboembolism 08/2020
1	Retinal Artery Occlusion 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 01/2020
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2020
1	Moyamoya Disease (Moya-Moya Disease) 02/2019
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 01/2019
1	Brain Hypoxia (Cerebral Hypoxia) 01/2019
1	Retinal Hemorrhage 08/2018
1	Cerebral Infarction 07/2018
1	Lacunar Stroke 07/2018
1	Opsoclonus-Myoclonus Syndrome (Kinsbourne Syndrome) 09/2017
1	Neurologic Manifestations (Neurological Manifestations) 07/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 07/2017
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2016
1	Parkinson Disease (Parkinson's Disease) 11/2016
1	Disease Progression 09/2013
1	Optic Nerve Diseases (Optic Neuropathy) 09/2013

Drug/Important Bio-Agent (IBA)

13	Retinaldehyde (Retinal)IBA 03/2022 - 07/2017
4	Tissue Plasminogen Activator (Alteplase)FDA Link 02/2021 - 01/2017
3	Amyloid (Amyloid Fibrils)IBA 10/2021 - 01/2019
3	Amyloid beta-PeptidesIBA 01/2020 - 08/2018
2	MicroRNAs (MicroRNA)IBA 07/2021 - 12/2019
2	Rituximab (Mabthera)FDA Link 09/2017 - 12/2016
1	Estrogens (Estrogen)FDA Link 11/2021
1	Antiviral Agents (Antivirals)IBA 11/2020
1	fibrin fragment D (D-dimer)IBA 08/2020
1	apixabanIBA 08/2020
1	AnticoagulantsIBA 08/2020
1	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 08/2020
1	Antiphospholipid AntibodiesIBA 08/2020
1	Enoxaparin (Lovenox)FDA LinkGeneric 08/2020
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 01/2020
1	CurcuminIBA 01/2020
1	Protein Isoforms (Isoforms)IBA 02/2019
1	Prednisone (Sone)FDA LinkGeneric 01/2019
1	Neuroprotective AgentsIBA 01/2016
1	Fluorescein (Funduscein)FDA LinkGeneric 09/2013

Therapy/Procedure

8	Therapeutics 03/2022 - 12/2016
1	Thrombectomy 01/2022
1	Immunomodulation 11/2020
1	Thrombolytic Therapy 01/2020
1	Lasers (Laser) 01/2020
1	Catheters 01/2019
1	Deep Brain Stimulation 11/2016
1	Induced Hypothermia 01/2016